Inventor
LEUNG SHUI-ON
US26 patents
⚠️ This page may combine multiple inventors who share the name “LEUNG SHUI-ON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IMMUNOMEDICS INC
22 patentsUS7541440B2Jun 2, 2009
Chimeric, human and humanized anti-granulocyte antibodies and methods of use
IMMUNOMEDICS INC129 citations99
US7312318B2Dec 25, 2007
Internalizing anti-CD74 antibodies and methods of use
IMMUNOMEDICS INC243 citations99
US6962702B2Nov 8, 2005
Production and use of novel peptide-based agents for use with bi-specific antibodies
IMMUNOMEDICS INC126 citations99
US6472511B1Oct 29, 2002
Stimulation of an immune response with antibodies labeled with the α-galactosyl epitope
IMMUNOMEDICS INC160 citations99
US6254868B1Jul 3, 2001
Glycosylated humanized B-cell specific antibodies
IMMUNOMEDICS INC206 citations99
US6187287B1Feb 13, 2001
Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells
IMMUNOMEDICS INC402 citations99
US5789554AAug 4, 1998
Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells
IMMUNOMEDICS INC596 citations99
US5635603AJun 3, 1997
Preparation and use of immunoconjugates
IMMUNOMEDICS INC176 citations98
US5443953AAug 22, 1995
Preparation and use of immunoconjugates
IMMUNOMEDICS INC338 citations98
US7919087B2Apr 5, 2011
Internalizing anti-CD74 antibodies and methods of use
IMMUNOMEDICS INC33 citations96
US7074405B1Jul 11, 2006
Use of bi-specific antibodies for pre-targeting diagnosis and therapy
IMMUNOMEDICS INC61 citations96
US6090381AJul 18, 2000
Stimulation of an immune response with antibodies labeled with the . .alpha-galactosyl epitope
IMMUNOMEDICS INC46 citations96
US6730300B2May 4, 2004
Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications
IMMUNOMEDICS INC61 citations95
US7429381B2Sep 30, 2008
Production and use of novel peptide-based agents for use with bi-specific antibodies
IMMUNOMEDICS INC14 citations93
US7052872B1May 30, 2006
Bi-specific antibodies for pre-targeting diagnosis and therapy
IMMUNOMEDICS INC49 citations93
US6953675B2Oct 11, 2005
Landscaped antibodies and antibody fragments for clinical use
IMMUNOMEDICS INC43 citations93
US6440386B1Aug 27, 2002
Stabilized radiophosphate-labeled proteins
IMMUNOMEDICS INC12 citations74
US7666415B2Feb 23, 2010
Production and use of novel peptide-based agents for use with bi-specific antibodies
IMMUNOMEDICS INC1 citations63
US7563439B2Jul 21, 2009
Production and use of novel peptide-based agents for use with bi-specific antibodies
IMMUNOMEDICS INC1 citations63
US7943343B2May 17, 2011
Production and use of novel peptide-based agents for use with bi-specific antibodies
IMMUNOMEDICS INC0 citations52
US7413736B2Aug 19, 2008
Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications
IMMUNOMEDICS INC0 citations51
US7348419B2Mar 25, 2008
Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications
IMMUNOMEDICS INC0 citations51
SINOMAB BIOSCIENCE LTD
3 patentsUS9371396B2Jun 21, 2016
Anti-CD22 anti-idiotypic antibodies and uses thereof
SINOMAB BIOSCIENCE LTD8 citations82
US12173065B2Dec 24, 2024
Fusion proteins comprising extracellular domain of human CD22
SINOMAB BIOSCIENCE LTD0 citations61
US10613099B2Apr 7, 2020
Cell lines expressing surface bound anti-idiotype antibodies against anti-CD22 antibodies and uses thereof
SINOMAB BIOSCIENCE LTD0 citations51